Showing 4 posts of 4 posts found.


KaloBios cuts ties with former CEO Martin Shkreli, outlines ‘maniacal’ turnaround plan

August 30, 2016
Research and Development, Sales and Marketing Daraprim, KaloBios, Martin Shkreli, Retrophin, benznidazole, turnaround

Two months after small drugmaker KaloBios returns from bankruptcy, controversial industry figure Martin Shkreli is no longer a stakeholder in …


KaloBios announces new affordable pricing model, refuses to engage in “price gouging”

April 12, 2016
Manufacturing and Production, Sales and Marketing CEO, Drug pricing, KaloBios, Martin Shkreli, Shkreli, affordable, price gouging, price model, responsible

Price gouging has become synonymous with drug costs in the US, with the infamous Martin Shkreli and troubled Valeant becoming …


KaloBios files for bankruptcy after Shkreli arrest

January 4, 2016
Sales and Marketing KaloBios, Martin Shkreli

KaloBios has filed for bankruptcy in the wake of chief executive Martin Shkreli’s arrest on securities fraud charges last month …

Sanofi Pasteur collaborates on novel biologics

January 12, 2010
Research and Development KaloBios, Sanofi, Sanofi Pasteur, cystic fibrosis, infection, vaccines

Sanofi Aventis’ vaccines division has partnered with US biotech KaloBios to develop a number of novel biologic treatments. Sanofi Pasteur …

Latest content